Horrell Capital Management’s Pfizer PFE Stock Holding History

Horrell Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.63K	Hold	400	–	–	﹤0.01%	149
2026 Q1	$11.2K	Hold	400	–	–	0.01%	144
2025 Q4	$9.96K	Hold	400	–	–	﹤0.01%	146
2025 Q3	$10.2K	Sell	400 -80	-17%	-$1.98K	﹤0.01%	147
2025 Q2	$11.6K	Buy	480 +80	+20%	+$1.87K	﹤0.01%	142
2025 Q1	$10.1K	Hold	400	–	–	﹤0.01%	143
2024 Q4	$11K	Hold	400	–	–	﹤0.01%	165
2024 Q3	$12K	Hold	400	–	–	﹤0.01%	163
2024 Q2	$11K	Sell	400 -159	-28%	-$4.38K	﹤0.01%	166
2024 Q1	$11K	Hold	559	–	–	﹤0.01%	173
2023 Q4	$16K	Buy	559 +400	+252%	+$12.1K	﹤0.01%	159
2023 Q3	$5K	Hold	159	–	–	﹤0.01%	188
2023 Q2	$6K	Hold	159	–	–	﹤0.01%	183
2023 Q1	$6K	Hold	159	–	–	﹤0.01%	183
2022 Q4	$8K	Hold	159	–	–	﹤0.01%	173
2022 Q3	$7K	Hold	159	–	–	﹤0.01%	168
2022 Q2	$8K	Hold	159	–	–	﹤0.01%	165
2022 Q1	$8K	Hold	159	–	–	﹤0.01%	168
2021 Q4	$9K	Hold	159	–	–	﹤0.01%	165
2021 Q3	$7K	Hold	159	–	–	﹤0.01%	170
2021 Q2	$6K	Hold	159	–	–	﹤0.01%	176
2021 Q1	$6K	Hold	159	–	–	﹤0.01%	175
2020 Q4	$6K	Sell	159 -9	-5%	-$330	﹤0.01%	164
2020 Q3	$6K	Hold	168	–	–	﹤0.01%	151
2020 Q2	$5K	Hold	168	–	–	﹤0.01%	153
2020 Q1	$5K	Hold	168	–	–	﹤0.01%	149
2019 Q4	$6K	Hold	168	–	–	﹤0.01%	155
2019 Q3	$6K	Hold	168	–	–	﹤0.01%	162
2019 Q2	$7K	Hold	168	–	–	﹤0.01%	153
2019 Q1	$7K	Hold	168	–	–	﹤0.01%	153
2018 Q4	$7K	Hold	168	–	–	﹤0.01%	152
2018 Q3	$7K	Hold	168	–	–	﹤0.01%	152
2018 Q2	$6K	Hold	168	–	–	﹤0.01%	160
2018 Q1	$6K	Hold	168	–	–	﹤0.01%	151
2017 Q4	$6K	Hold	168	–	–	﹤0.01%	151
2017 Q3	$6K	Hold	168	–	–	﹤0.01%	147
2017 Q2	$5K	Hold	168	–	–	﹤0.01%	150
2017 Q1	$5K	Hold	168	–	–	﹤0.01%	150
2016 Q4	$5K	Hold	168	–	–	﹤0.01%	152
2016 Q3	$5K	Sell	168 -21	-11%	-$702	﹤0.01%	146
2016 Q2	$6K	Buy	189 +21	+13%	+$670	﹤0.01%	155
2016 Q1	$5K	Hold	168	–	–	﹤0.01%	157
2015 Q4	$5K	Hold	168	–	–	﹤0.01%	152
2015 Q3	$5K	Hold	168	–	–	﹤0.01%	170
2015 Q2	$5K	Sell	168 -7,080	-98%	-$231K	﹤0.01%	176
2015 Q1	$239K	Hold	7,248	–	–	0.1%	101
2014 Q4	$214K	Hold	7,248	–	–	0.09%	105
2014 Q3	$203K	Sell	7,248 -280	-4%	-$7.86K	0.1%	105
2014 Q2	$212K	Hold	7,528	–	–	0.1%	111
2014 Q1	$229K	Hold	7,528	–	–	0.12%	107
2013 Q4	$219K	Hold	7,528	–	–	0.11%	104
2013 Q3	$205K	Hold	7,528	–	–	0.11%	104
2013 Q2	$200K	Buy	+7,528	New	+$208K	0.11%	107

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Horrell Capital Management's PFE Position: Q2 2026 in Review

Horrell Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 400 shares worth $9.63K. The position accounts for ﹤0.01% of the portfolio, ranked #149.

Horrell Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $239K in Q1 2015. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Horrell Capital Management held 400 shares of Pfizer worth $9.63K as of Q2 2026.
Horrell Capital Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Horrell Capital Management's portfolio in Q2 2026, its #149 holding.
Horrell Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Horrell Capital Management's Pfizer position peaked at $239K in Q1 2015.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Horrell Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.